カテゴリー： Market Monitor Global, 世界, 医療/バイオ

肺腫瘍塞栓術の世界市場見通し2023年-2029年

◆英語タイトル：Lung Tumor Embolization Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY7708 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：67 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Lung Tumor Embolization Market 調査レポートは次の情報を含め、グローバルにおけるの肺腫瘍塞栓術市場規模と予測を収録しています。・世界の肺腫瘍塞栓術市場：売上、2018年-2023年、2024年-2029年
・世界の肺腫瘍塞栓術市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の肺腫瘍塞栓術市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「肝動脈化学塞栓術（TACE）」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

肺腫瘍塞栓術のグローバル主要企業は、Inari Medical、 Penumbra、 Tendfo、 Medtronic、 Olympusなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、肺腫瘍塞栓術のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の肺腫瘍塞栓術市場：タイプ別、2018年-2023年、2024年-2029年
世界の肺腫瘍塞栓術市場：タイプ別市場シェア、2022年
・肝動脈化学塞栓術（TACE）、肝動脈放射線塞栓術（TARE）、その他

世界の肺腫瘍塞栓術市場：用途別、2018年-2023年、2024年-2029年
世界の肺腫瘍塞栓術市場：用途別市場シェア、2022年
・病院、外来手術センター

世界の肺腫瘍塞栓術市場：地域・国別、2018年-2023年、2024年-2029年
世界の肺腫瘍塞栓術市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における肺腫瘍塞栓術のグローバル売上、2018年-2023年
・主要企業における肺腫瘍塞栓術のグローバル売上シェア、2022年
・主要企業における肺腫瘍塞栓術のグローバル販売量、2018年-2023年
・主要企業における肺腫瘍塞栓術のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Inari Medical、 Penumbra、 Tendfo、 Medtronic、 Olympus

*************************************************************

・調査・分析レポートの概要
肺腫瘍塞栓術市場の定義
市場セグメント
世界の肺腫瘍塞栓術市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の肺腫瘍塞栓術市場規模
世界の肺腫瘍塞栓術市場規模：2022年 VS 2029年
世界の肺腫瘍塞栓術市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの肺腫瘍塞栓術の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の肺腫瘍塞栓術製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：肝動脈化学塞栓術（TACE）、肝動脈放射線塞栓術（TARE）、その他
肺腫瘍塞栓術のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、外来手術センター
肺腫瘍塞栓術の用途別グローバル売上・予測

・地域別市場分析
地域別肺腫瘍塞栓術市場規模 2022年と2029年
地域別肺腫瘍塞栓術売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Inari Medical、 Penumbra、 Tendfo、 Medtronic、 Olympus
...

Transcatheter bronchial arterial chemoembolization is a minimally invasive operation. To put it simply, in the case of no operation, a tiny channel with a diameter of about 2 mm is made on the skin. Under the guidance of angiography machine, the tumor blood supply vessels are found and then the chemotherapy drugs are infused through the catheter, and then the tumor blood vessel is embolized with embolization agent to block the tumor blood supply. For the tumor is to kill (high concentration of anticancer drugs) + “starve to death (blocking tumor blood vessels) double treatment of the tumor, the local lesions for the least trauma treatment method.
This report aims to provide a comprehensive presentation of the global market for Lung Tumor Embolization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Tumor Embolization. This report contains market size and forecasts of Lung Tumor Embolization in global, including the following market information:
Global Lung Tumor Embolization Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Lung Tumor Embolization market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Transarterial chemoembolization (TACE) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lung Tumor Embolization include Inari Medical, Penumbra, Tendfo, Medtronic and Olympus, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung Tumor Embolization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Tumor Embolization Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Lung Tumor Embolization Market Segment Percentages, by Type, 2022 (%)
Transarterial chemoembolization (TACE)
Transarterial Radioembolization (TARE)
Others
Global Lung Tumor Embolization Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Lung Tumor Embolization Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Global Lung Tumor Embolization Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Lung Tumor Embolization Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Tumor Embolization revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lung Tumor Embolization revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Inari Medical
Penumbra
Tendfo
Medtronic
Olympus
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Tumor Embolization, market overview.
Chapter 2: Global Lung Tumor Embolization market size in revenue.
Chapter 3: Detailed analysis of Lung Tumor Embolization company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Tumor Embolization in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Lung Tumor Embolization Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Tumor Embolization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Tumor Embolization Overall Market Size
2.1 Global Lung Tumor Embolization Market Size: 2022 VS 2029
2.2 Global Lung Tumor Embolization Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Tumor Embolization Players in Global Market
3.2 Top Global Lung Tumor Embolization Companies Ranked by Revenue
3.3 Global Lung Tumor Embolization Revenue by Companies
3.4 Top 3 and Top 5 Lung Tumor Embolization Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Tumor Embolization Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Tumor Embolization Players in Global Market
3.6.1 List of Global Tier 1 Lung Tumor Embolization Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Tumor Embolization Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Lung Tumor Embolization Market Size Markets, 2022 & 2029
4.1.2 Transarterial chemoembolization (TACE)
4.1.3 Transarterial Radioembolization (TARE)
4.1.4 Others
4.2 By Type – Global Lung Tumor Embolization Revenue & Forecasts
4.2.1 By Type – Global Lung Tumor Embolization Revenue, 2018-2023
4.2.2 By Type – Global Lung Tumor Embolization Revenue, 2024-2029
4.2.3 By Type – Global Lung Tumor Embolization Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lung Tumor Embolization Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.2 By Application – Global Lung Tumor Embolization Revenue & Forecasts
5.2.1 By Application – Global Lung Tumor Embolization Revenue, 2018-2023
5.2.2 By Application – Global Lung Tumor Embolization Revenue, 2024-2029
5.2.3 By Application – Global Lung Tumor Embolization Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Lung Tumor Embolization Market Size, 2022 & 2029
6.2 By Region – Global Lung Tumor Embolization Revenue & Forecasts
6.2.1 By Region – Global Lung Tumor Embolization Revenue, 2018-2023
6.2.2 By Region – Global Lung Tumor Embolization Revenue, 2024-2029
6.2.3 By Region – Global Lung Tumor Embolization Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Lung Tumor Embolization Revenue, 2018-2029
6.3.2 US Lung Tumor Embolization Market Size, 2018-2029
6.3.3 Canada Lung Tumor Embolization Market Size, 2018-2029
6.3.4 Mexico Lung Tumor Embolization Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Lung Tumor Embolization Revenue, 2018-2029
6.4.2 Germany Lung Tumor Embolization Market Size, 2018-2029
6.4.3 France Lung Tumor Embolization Market Size, 2018-2029
6.4.4 U.K. Lung Tumor Embolization Market Size, 2018-2029
6.4.5 Italy Lung Tumor Embolization Market Size, 2018-2029
6.4.6 Russia Lung Tumor Embolization Market Size, 2018-2029
6.4.7 Nordic Countries Lung Tumor Embolization Market Size, 2018-2029
6.4.8 Benelux Lung Tumor Embolization Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Lung Tumor Embolization Revenue, 2018-2029
6.5.2 China Lung Tumor Embolization Market Size, 2018-2029
6.5.3 Japan Lung Tumor Embolization Market Size, 2018-2029
6.5.4 South Korea Lung Tumor Embolization Market Size, 2018-2029
6.5.5 Southeast Asia Lung Tumor Embolization Market Size, 2018-2029
6.5.6 India Lung Tumor Embolization Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Lung Tumor Embolization Revenue, 2018-2029
6.6.2 Brazil Lung Tumor Embolization Market Size, 2018-2029
6.6.3 Argentina Lung Tumor Embolization Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Lung Tumor Embolization Revenue, 2018-2029
6.7.2 Turkey Lung Tumor Embolization Market Size, 2018-2029
6.7.3 Israel Lung Tumor Embolization Market Size, 2018-2029
6.7.4 Saudi Arabia Lung Tumor Embolization Market Size, 2018-2029
6.7.5 UAE Lung Tumor Embolization Market Size, 2018-2029
7 Lung Tumor Embolization Companies Profiles
7.1 Inari Medical
7.1.1 Inari Medical Company Summary
7.1.2 Inari Medical Business Overview
7.1.3 Inari Medical Lung Tumor Embolization Major Product Offerings
7.1.4 Inari Medical Lung Tumor Embolization Revenue in Global Market (2018-2023)
7.1.5 Inari Medical Key News & Latest Developments
7.2 Penumbra
7.2.1 Penumbra Company Summary
7.2.2 Penumbra Business Overview
7.2.3 Penumbra Lung Tumor Embolization Major Product Offerings
7.2.4 Penumbra Lung Tumor Embolization Revenue in Global Market (2018-2023)
7.2.5 Penumbra Key News & Latest Developments
7.3 Tendfo
7.3.1 Tendfo Company Summary
7.3.2 Tendfo Business Overview
7.3.3 Tendfo Lung Tumor Embolization Major Product Offerings
7.3.4 Tendfo Lung Tumor Embolization Revenue in Global Market (2018-2023)
7.3.5 Tendfo Key News & Latest Developments
7.4 Medtronic
7.4.1 Medtronic Company Summary
7.4.2 Medtronic Business Overview
7.4.3 Medtronic Lung Tumor Embolization Major Product Offerings
7.4.4 Medtronic Lung Tumor Embolization Revenue in Global Market (2018-2023)
7.4.5 Medtronic Key News & Latest Developments
7.5 Olympus
7.5.1 Olympus Company Summary
7.5.2 Olympus Business Overview
7.5.3 Olympus Lung Tumor Embolization Major Product Offerings
7.5.4 Olympus Lung Tumor Embolization Revenue in Global Market (2018-2023)
7.5.5 Olympus Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Lung Tumor Embolization Market Opportunities & Trends in Global Market
Table 2. Lung Tumor Embolization Market Drivers in Global Market
Table 3. Lung Tumor Embolization Market Restraints in Global Market
Table 4. Key Players of Lung Tumor Embolization in Global Market
Table 5. Top Lung Tumor Embolization Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lung Tumor Embolization Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lung Tumor Embolization Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lung Tumor Embolization Product Type
Table 9. List of Global Tier 1 Lung Tumor Embolization Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Tumor Embolization Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Lung Tumor Embolization Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Lung Tumor Embolization Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lung Tumor Embolization Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Lung Tumor Embolization Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Lung Tumor Embolization Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lung Tumor Embolization Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Lung Tumor Embolization Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Lung Tumor Embolization Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lung Tumor Embolization Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Lung Tumor Embolization Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lung Tumor Embolization Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Lung Tumor Embolization Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lung Tumor Embolization Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Lung Tumor Embolization Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lung Tumor Embolization Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Lung Tumor Embolization Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lung Tumor Embolization Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Lung Tumor Embolization Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lung Tumor Embolization Revenue, (US$, Mn), 2024-2029
Table 30. Inari Medical Company Summary
Table 31. Inari Medical Lung Tumor Embolization Product Offerings
Table 32. Inari Medical Lung Tumor Embolization Revenue (US$, Mn) & (2018-2023)
Table 33. Inari Medical Key News & Latest Developments
Table 34. Penumbra Company Summary
Table 35. Penumbra Lung Tumor Embolization Product Offerings
Table 36. Penumbra Lung Tumor Embolization Revenue (US$, Mn) & (2018-2023)
Table 37. Penumbra Key News & Latest Developments
Table 38. Tendfo Company Summary
Table 39. Tendfo Lung Tumor Embolization Product Offerings
Table 40. Tendfo Lung Tumor Embolization Revenue (US$, Mn) & (2018-2023)
Table 41. Tendfo Key News & Latest Developments
Table 42. Medtronic Company Summary
Table 43. Medtronic Lung Tumor Embolization Product Offerings
Table 44. Medtronic Lung Tumor Embolization Revenue (US$, Mn) & (2018-2023)
Table 45. Medtronic Key News & Latest Developments
Table 46. Olympus Company Summary
Table 47. Olympus Lung Tumor Embolization Product Offerings
Table 48. Olympus Lung Tumor Embolization Revenue (US$, Mn) & (2018-2023)
Table 49. Olympus Key News & Latest Developments
List of Figures
Figure 1. Lung Tumor Embolization Segment by Type in 2022
Figure 2. Lung Tumor Embolization Segment by Application in 2022
Figure 3. Global Lung Tumor Embolization Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lung Tumor Embolization Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lung Tumor Embolization Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Tumor Embolization Revenue in 2022
Figure 8. By Type - Global Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 9. By Application - Global Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 10. By Type - Global Lung Tumor Embolization Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 12. By Application - Global Lung Tumor Embolization Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 14. By Region - Global Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 15. By Country - North America Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 16. US Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 20. Germany Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 21. France Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 28. China Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 32. India Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 34. Brazil Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Lung Tumor Embolization Revenue Market Share, 2018-2029
Figure 37. Turkey Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Lung Tumor Embolization Revenue, (US$, Mn), 2018-2029
Figure 41. Inari Medical Lung Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Penumbra Lung Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Tendfo Lung Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Medtronic Lung Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Olympus Lung Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 肺腫瘍塞栓術の世界市場見通し2023年-2029年(Lung Tumor Embolization Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

肺腫瘍塞栓術の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp